Click here to download

Empirical validation of Hypnotic Psychotherapy for Panic Disorder and Major Depression: Comparison with Cognitive Psychotherapy and Pharmacotherapy
Journal Title: IPNOSI 
Author/s: Alessandro Calzeroni, Alessandro Baffigi, Silvia Giacosa, Costanza Licari, Giampiero Mosconi 
Year:  2017 Issue: Language: Italian 
Pages:  22 Pg. 5-26 FullText PDF:  343 KB
DOI:  10.3280/IPN2017-002001
(DOI is like a bar code for intellectual property: to have more infomation:  clicca qui   and here 


To deepen the knowledge of the ‘evidence based medicine’ indications for Hypnotic Psychotherapy, this study proposes: 1) to verify the efficacy and tolerability of Hypnotic Psychotherapy in the short- and long-term treatment of patients with panic disorder and major depression; 2) to apply evaluation scales similar to those used in psychopharmacological studies; 3) to replicate in the Italian population standardized comparison methods among therapies used in international studies; 4) to suggest Hypnotic Psychotherapy as a first cost-socioeconomic effective choice in Italian guide-lines for management of main psychological stress-correlated disorders.
Keywords: Hypnotic psychotherapy, major depression, panic disorder, evidence based medicine, socioeconomic costs of mental disease.

  1. Alladin A., Sabatini L., Amundson J.K. (2007). Evidence-Based Practice in Clinical Hypnosis. International Journal of Clinical and Experimental Hypnosis, 55(2): 115-130., 10.1080/00207140601177871DOI: 10.1080/00207140601177871
  2. Altamura A.C. (1996). Linee guida per il trattamento psicofarmacologico del Di-sturbo di panico. Rivista di Psichiatria, 31(5): 223-232.
  3. American Psychiatric Association (1993). Practice Guidelines for Major Depressive Disorders in Adults. American Journal of Psychiatry, 150(4): 1-26.
  4. American Psychiatric Association (1998): Practice Guidelines for patients with Panic Disorders. American Journal of Psychiatry, 155(5): 1-34.
  5. AMISI (2015). La teoria della mente nella psicoterapia ipnotica neo-ericksoniana. Quarto Manifesto teorico-didattico, Rivista Italiana di Ipnosi e Psicoterapia Ipnotica, 35(2): 161-164.
  6. AMISI (2016). Hypnosis, Hypnotic psychotherapy and ‘neoericksonian’ principles: A Theoretical Didactic Manifesto, Update. Published in 2016/2 issue of ESH Newsletter, p. 14.
  7. Andrews G., Creamer M., Crino R., Hunt C., Lampe L., Page A. (2003). Trattamento dei disturbi d’ansia. Guide per il clinico e manuali per chi soffre del di-sturbo. Torino: Centro Scientifico.
  8. Baxter L., Schwartz J., Bergman K., Szuba M., Guze B., Mazziotta J., Alazraki A., Selin C., Ferng H., Munford P. Phelps M. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Archives of General Psychiatry, 49(9): 681-689.
  9. Beck A. (1967). La depressione. Torino: Boringhieri.
  10. Beck A., Ward C.H., Mendelson M., Mock J., Erbaugh J. (1961). An inventory for measuroing depression. Arch. Gen. Psych, 4: 561-71.
  11. Beck A., Hollon S., Young J., Bedrosian R., Budenz D. (1985). Treatment of depression with cognitive therapy and amitriptyline. Archives of General Psychiatry, 42(2): 142-148.
  12. Bellantuono C., Tansella M. (1994). Gli psicofarmaci nella pratica clinica. Roma: Il Pensiero Scientifico.
  13. Blackburn S., Glen A., Whalley L., Christie J. (1981). The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. British Journal of Psychiatry, 139: 181-189.
  14. Bukner R., Andrews-Hanna J., Schacter D. (2008). The brain’s default network: anatomy, function and relevance to disease. Annals of the New York Academy of Sciences, 1124: 1-38.
  15. Calzeroni A., Limonta G., D’Ambrosio V., Gislon G., Zapparoli G. (1996). Short and long term cognitive psychotherapy for depression. Italian Journal of Psychiatry and Behavioral Sciences, 3: 89-94.
  16. Calzeroni A., Mosconi G. (2003). Psicoterapia Ipnotica: l’approccio neoericksoniano per la cura del Disturbo da attacchi di Panico. Roma: Il Pensiero Scientifico.
  17. Calzeroni A., Cammarano M., Sileoni A., Scarone S. (2004). Cognitive psychotherapy, pharmacotherapy and their integration for panic disorder: an acute and 12- months follow-up study. Italian Journal for Psychiatry and Behavioural Sciences, 14(2-3): 79-88.
  18. Calzeroni A. (2005). La validazione della Psicoterapia Ipnotica; caso clinico trattato secondo il protocollo previsto dal progetto AMISI. Rivista Italiana di Ipnosi e Psicoterapia Ipnotica, 25(1): 7-21.
  19. Calzeroni A., Percudani M. (2009). Analisi dei costi diretti e indiretti della Psicoterapia Ipnotica nel trattamento del Disturbo di Panico. Rivista Italiana di Ipnosi e Psicoterapia Ipnotica, 29(3): 74-80.
  20. Calzeroni A. (2015a). Psicoterapia ipnotica nel trattamento della depressione: risultati a breve e lungo termine di uno studio naturalistico. Rivista Italiana di Ipnosi e Psicoterapia Ipnotica, 35(2): 11-13.
  21. Calzeroni A. (2015b). Suggestione diretta e indiretta in Psicoterapia Ipnotica, quale la retta via? Rivista Italiana di Ipnosi e Psicoterapia Ipnotica, 35(3): 8-11.
  22. Chambless D., Sanderson W., Shoham V., Johnson S., Pope K., Crits-Christoph P., Baker M., Johnson B., Woody S., Sue S., Beutler L., Williams D., McCurry S. (1998): Update on Empirically validated therapies. The Clinical Psychologist, 51: 1-16.
  23. Chambless D., Ollendick T. (2001). Empirically supported psychological interventions: controversies and evidences. Annual Review of Psychology, 52: 685-716.
  24. Clark D. (1995). Perceived limitations of Standard Cognitive Therapy: a consideration of efforts to revise Beck’s theory and therapy. Journal of Cognitive Psychotherapy, 9(3): 153-172.
  25. Crocker M., Siekmann J. (2010): Resource-Adaptive Cognitive Processes. Berlin: Springer.
  26. Elkin I., Shea M., Watkins J., Imber S., Sotsky S., Collins J., Glass D., Pilkonis P., Leber W., Docherty J., Fiester S., Parloff M. (1989). NIMH treatment of depression collaborative research program: general effectiveness of treatments. Archives of General Psychiatry, 46: 971-982.
  27. Kirsch I., Moore T., Nicholls S. (2002). The emperor’s new drugs: an analysis of antidepressant medication data submitted to the US Food and Drug Administration. Prevention & Treatment, American Psychological Association, http://psycnet.apa.org/record/2002-14079-003
  28. Mammini C., Balugani R. (2014). La terapia naturalistica di Milton Erickson. Milano: Franco Angeli.
  29. Mosconi G. (1998). Teoretica e pratica della Psicoterapia Ipnotica. Milano: Franco Angeli.
  30. Mosconi G. (2003). Evoluzione dell’ipnosi dalla suggestione alla psicoterapia neoericksoniana. Rivista di Medicina, Psicologia e Pedagogia, 25: 62-64.
  31. Pancheri P. (1994). Linee guida per il trattamento farmacologico dell’episodio depressivo. Rivista Italiana di Psichiatria, 29: 5.
  32. Percudani M. (2000). Valutare i costi nell’attività clinica di routine dei Servizi Psichiatrici. Sviluppo e applicazione di uno strumento ad hoc, Epidemiologia e Psichiatria Sociale.
  33. Percudani M., Calzeroni A. (2001). Analisi dei costi diretti ed indiretti generati da soggetti con disturbo da attacchi di panico prima e dopo un trattamento psicoterapeutico di gruppo, in Il trattamento cognitivo-comportamentale dei disturbi d’ansia: dal protocollo sperimentale alla psicoterapia per il servizio pubblico. Regione Lombardia, pp. 149-153.
  34. Porto P., Oliveira L., Mari J., Volchan E., Figueira I., Ventura P. (2009). Does the behavioral Therapy change the brain? A systematic review of neuroimaging in anxiety disorders, Journal of Neuropsychiatry and Clinical Neurosciences, 12(2): 114-125.
  35. Rice D., Miller L. (1998). Health economics and cost implications of anxiety and other mental disorder in the United States. British Journal of Psychiatry, 173(34): 4-9.
  36. Roth A., Fonagy P. (1997). Psicoterapie e prove di efficacia. Quale terapia per quale paziente. Roma: Il Pensiero Scientifico.
  37. Sackett D., Richardson W., Rosenberg W., Haynes R. (1997). Evidence-Based Medicine: How to Practice and Teach EBM. London: Churchill Livingstone.
  38. Schacter D., Addis D. (2007). Neuroscience of constructive memory: remembering the past and imagining the future, Journal Philosophical Transactions Biology Science, 362 (1481).
  39. Shapiro F. (2007). EDMR and case conceptualization from an adaptive information processing perspective, in Shapiro F., Kaslow F., Maxfield L., Handbook of EDMR and family therapy processes. New York: Wiley, pp. 3-36.
  40. Sheehan DV. (1983). The anxiety disease, in Sheehan D.V. The Anxiety Disease. New York: Charles Scribner’s Sons.
  41. Yapko M. (1997). Rompere gli schemi della depressione. Firenze: Ponte alle Grazie.
  42. Yapko M. (2003). Lavorare con l’ipnosi. Milano: FrancoAngeli.
  43. Zeig J. (1995). Metodi diretti e indiretti, in Del Castello E., Loriedo C., a cura di, Tecniche dirette e indirette in ipnosi e psicoterapia. Milano: FrancoAngeli.

Alessandro Calzeroni, Alessandro Baffigi, Silvia Giacosa, Costanza Licari, Giampiero Mosconi, Empirical validation of Hypnotic Psychotherapy for Panic Disorder and Major Depression: Comparison with Cognitive Psychotherapy and Pharmacotherapy in "IPNOSI" 2/2017, pp. 5-26, DOI:10.3280/IPN2017-002001

   

FrancoAngeli is a member of Publishers International Linking Association a not for profit orgasnization wich runs the CrossRef service, enabing links to and from online scholarly content